ARCHIVES

Elizabeth Miller Will Be Named to Cancer Panel

This article is from The Cancer Letter archive.

Vol. 03 No. 24 | June 17, 1977

Download PDF Visit The Full Archive

Related Articles

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978